Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / Common Stock, par value $0.007 per share
-
Shares outstanding
-
28.7M
-
Number of holders
-
6
-
Total 13F shares, excl. options
-
102K
-
Shares change
-
+18.9K
-
Total reported value, excl. options
-
$193K
-
Value change
-
+$54.5K
-
Number of buys
-
4
-
Number of sells
-
-3
-
Price
-
$1.89
Significant Holders of bioAffinity Technologies, Inc. - Common Stock, par value $0.007 per share (BIAF) as of Q1 2023
8 filings reported holding BIAF - bioAffinity Technologies, Inc. - Common Stock, par value $0.007 per share as of Q1 2023.
bioAffinity Technologies, Inc. - Common Stock, par value $0.007 per share (BIAF) has 6 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 102K shares
of 28.7M outstanding shares and own 0.36% of the company stock.
Largest 8 shareholders include CAPTRUST FINANCIAL ADVISORS (43.6K shares), TWO SIGMA INVESTMENTS, LP (26.6K shares), STATE STREET CORP (17.6K shares), Creative Planning (12.1K shares), UBS Group AG (2.41K shares), WELLS FARGO & COMPANY/MN (34 shares), Financial Engines Advisors L.L.C. (0 shares), and MORGAN STANLEY (0 shares).
This table shows the top 6 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.